Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma × IFL protocol × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 7 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Melanoma 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Ras-mutated Metastatic Colorectal Cancer 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Gastroesophageal Adenocarcinoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Carcinoma, Merkel Cell 1 Breast Neoplasms 1

Interventions

pembrolizumab 4 zolbetuximab 3 Oxaliplatin 3 Fluorouracil 3 Capecitabine 3 trastuzumab deruxtecan 2 durvalumab 2 Trastuzumab 2 Radiosurgery 2 Leucovorin 2 Gemcitabine 2 Dexamethasone 2 Cisplatin 2 Androgen Antagonists 2 130-nm albumin-bound paclitaxel 2 tucatinib 1 relacorilant 1 pralsetinib 1 lenvatinib 1 fludarabine 1 cemiplimab 1 atezolizumab 1 Valacyclovir 1 Tumor Burden 1 Tadalafil 1 Quality of Life 1 Prostatectomy 1 Prodrugs 1 Prednisone 1 Prednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡